Epilepsy, a prevalent neurological disorder, continues to challenge healthcare professionals despite progress in its management. Recent advancements, however, offer renewed hope.
Newer AEDs, such as Brivaracetam and Perampanel, have shown promise in controlling seizures with fewer side effects, enhancing patient compliance.
Techniques like Vagus Nerve Stimulation (VNS) and Responsive Neurostimulation (RNS) have demonstrated efficacy in drug-resistant epilepsy, reducing seizure frequency and improving quality of life.
Minimally invasive procedures, including Laser Interstitial Thermal Therapy (LITT), provide a safer and more efficient alternative to traditional resective surgery.
Genetic testing has enabled personalized treatment strategies, significantly improving outcomes in genetically defined epilepsies.
These advancements in epilepsy management underscore the importance of continuous learning and adaptation in delivering optimal patient care.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation